Etonogestrel and Ethinyl Estradiol · ETONOGESTREL .12 mg/d; ETHINYL ESTRADIOL .015 mg/d · Insert, Extended Release · Vaginal · Teva Pharmaceuticals USA, Inc.
NDC 00093-7679-02 · 3 POUCH in 1 CARTON / 21 d in 1 POUCH · ANDA · View full market →
6 companies supply this market — a reasonable cushion if one runs into trouble. The generic price is down 10% over the past year, to $47.17 per unit. The brand (NuvaRing) runs $155.70 per unit — 3.3× more. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Matched to CMS's representative package for this drug (NDC 66993-0605-36) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.
Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 10 quarters since 2024.
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.
The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| A-S Medication Solutions | ETONOGESTREL .12 mg/d; ETHINYL ESTRADIOL .015 mg/d | Aug 26, 2026 | Sep 3, 2026 |
| N.V. Organon | ETONOGESTREL 11.7 mg/1; ETHINYL ESTRADIOL 2.7 mg/1 | Aug 20, 2026 | Sep 3, 2026 |
| Advanz Pharma (US) Corp. | ETONOGESTREL .12 mg/d; ETHINYL ESTRADIOL .015 mg/d | Aug 26, 2026 | Sep 2, 2026 |
| Organon LLC | ETONOGESTREL .12 mg/d; ETHINYL ESTRADIOL .015 mg/d | Aug 26, 2026 | Sep 2, 2026 |
| Prasco Laboratories | ETONOGESTREL .12 mg/d; ETHINYL ESTRADIOL .015 mg/d | Aug 26, 2026 | Sep 2, 2026 |
| Teva Pharmaceuticals USA, Inc. | ETONOGESTREL .12 mg/d; ETHINYL ESTRADIOL .015 mg/d | Aug 26, 2026 | Sep 2, 2026 |
| A-S Medication Solutions | ETONOGESTREL .015 mg/d; ETHINYL ESTRADIOL .12 mg/d | Jul 22, 2026 | Aug 21, 2026 |
| Advanz Pharma (US) Corp. | ETONOGESTREL .015 mg/d; ETHINYL ESTRADIOL .12 mg/d | Jul 22, 2026 | Aug 19, 2026 |
| N.V. Organon | ETONOGESTREL 2.7 mg/1; ETHINYL ESTRADIOL 11.7 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Organon LLC | ETONOGESTREL .015 mg/d; ETHINYL ESTRADIOL .12 mg/d | Jul 22, 2026 | Aug 19, 2026 |
| Prasco Laboratories | ETONOGESTREL .015 mg/d; ETHINYL ESTRADIOL .12 mg/d | Jul 22, 2026 | Aug 19, 2026 |
| Teva Pharmaceuticals USA, Inc. | ETONOGESTREL .015 mg/d; ETHINYL ESTRADIOL .12 mg/d | Jul 22, 2026 | Aug 19, 2026 |
| A-S Medication Solutions | ETHINYL ESTRADIOL .015 mg/d; ETONOGESTREL .12 mg/d | Jul 15, 2026 | Jul 16, 2026 |
| Advanz Pharma (US) Corp. | ETHINYL ESTRADIOL .015 mg/d; ETONOGESTREL .12 mg/d | Jul 15, 2026 | Jul 15, 2026 |
| N.V. Organon | ETHINYL ESTRADIOL 2.7 mg/1; ETONOGESTREL 11.7 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
| Organon LLC | ETHINYL ESTRADIOL .015 mg/d; ETONOGESTREL .12 mg/d | Jul 15, 2026 | Jul 15, 2026 |
| Prasco Laboratories | ETHINYL ESTRADIOL .015 mg/d; ETONOGESTREL .12 mg/d | Jul 15, 2026 | Jul 15, 2026 |
| Teva Pharmaceuticals USA, Inc. | ETHINYL ESTRADIOL .015 mg/d; ETONOGESTREL .12 mg/d | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Etonogestrel and Ethinyl Estradiol — NDC 00093-7679-02," retrieved September 3, 2026, https://drugdashboards.com/drug/00093767902.
Free to cite with attribution — see how the data is put together.